{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T12:33:51Z","timestamp":1780662831638,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Comp Hepatol"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The availability of non-rodent animal models for human cirrhosis is limited. We investigated whether privately-owned dogs (<jats:italic>Canis familiaris<\/jats:italic>) are potential model animals for liver disease focusing on regenerative pathways. Several forms of canine hepatitis were examined: Acute Hepatitis (AH), Chronic Hepatitis (CH), Lobular Dissecting Hepatitis (LDH, a specific form of micronodulair cirrhosis), and Cirrhosis (CIRR). Canine cirrhotic samples were compared to human liver samples from cirrhotic stages of alcoholic liver disease (hALC) and chronic hepatitis C infection (hHC).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Canine specific mRNA expression of the regenerative hepatocyte growth factor (HGF) signaling pathway and relevant down-stream pathways were measured by semi-quantitative PCR and Western blot (STAT3, PKB, ERK1\/2, and p38-MAPK). In all canine groups, levels of c-MET mRNA (proto-oncogenic receptor for HGF) were significantly decreased (p &lt; 0.05). Surprisingly, ERK1\/2 and p38-MAPK were increased in CH and LDH. In the human liver samples Western blotting indicated a high homology of down-stream pathways between different etiologies (hALC and hHC). Similarly activated pathways were found in CIRR, hALC, and hHC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>In canine hepatitis and cirrhosis the major regenerative downstream pathways were activated. Signaling pathways are similarly activated in human cirrhotic liver samples, irrespective of the differences in etiology in the human samples (alcohol abuse and HCV-infection). Therefore, canine hepatitis and cirrhosis could be an important clinical model to evaluate novel interventions prior to human clinical trials.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1476-5926-6-8","type":"journal-article","created":{"date-parts":[[2007,8,2]],"date-time":"2007-08-02T18:16:58Z","timestamp":1186078618000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Major HGF-mediated regenerative pathways are similarly affected in human and canine cirrhosis"],"prefix":"10.1186","volume":"6","author":[{"given":"Bart","family":"Spee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Arends","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted SGAM","family":"van den Ingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Roskams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Rothuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis C","family":"Penning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,7,31]]},"reference":[{"key":"109_CR1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1665-2681(19)32034-4","volume":"5","author":"D Motola-Kuba","year":"2006","unstructured":"Motola-Kuba D, Zamora-Valdes D, Uribe M, Mendez-Sanchez N: Hepatocellular carcinoma. An overview. Ann Hepatol. 2006, 5: 16-24.","journal-title":"Ann Hepatol"},{"key":"109_CR2","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/hep.21347","volume":"44","author":"R Williams","year":"2006","unstructured":"Williams R: Global challenges in liver disease. Hepatology. 2006, 44: 521-526. 10.1002\/hep.21347.","journal-title":"Hepatology"},{"key":"109_CR3","first-page":"237","volume":"117","author":"C Constandinou","year":"2005","unstructured":"Constandinou C, Henderson N, Iredale JP: Modeling liver fibrosis in rodents. Methods Mol Med. 2005, 117: 237-250.","journal-title":"Methods Mol Med"},{"key":"109_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.0959-9673.2006.00465.x","volume":"87","author":"QM Anstee","year":"2006","unstructured":"Anstee QM, Goldin RD: Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol. 2006, 87: 1-16. 10.1111\/j.0959-9673.2006.00465.x.","journal-title":"Int J Exp Pathol"},{"key":"109_CR5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11011-005-7927-z","volume":"20","author":"M Belanger","year":"2005","unstructured":"Belanger M, Butterworth RF: Acute liver failure: a critical appraisal of available animal models. Metab Brain Dis. 2005, 20: 409-423. 10.1007\/s11011-005-7927-z.","journal-title":"Metab Brain Dis"},{"key":"109_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1055\/s-2006-939760","volume":"26","author":"M Dandri","year":"2006","unstructured":"Dandri M, Lutgehetmann M, Volz T, Petersen J: Small animal model systems for studying hepatitis B virus replication and pathogenesis. Semin Liver Dis. 2006, 26: 181-191. 10.1055\/s-2006-939760.","journal-title":"Semin Liver Dis"},{"key":"109_CR7","first-page":"325","volume":"27","author":"AA Nanji","year":"2003","unstructured":"Nanji AA, French SW: Animal models of alcoholic liver disease--focus on the intragastric feeding model. Alcohol Res Health. 2003, 27: 325-330.","journal-title":"Alcohol Res Health"},{"key":"109_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000090165","volume":"23","author":"SV Siegmund","year":"2005","unstructured":"Siegmund SV, Haas S, Singer MV: Animal models and their results in gastrointestinal alcohol research. Dig Dis. 2005, 23: 181-194. 10.1159\/000090165.","journal-title":"Dig Dis"},{"key":"109_CR9","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1101\/gr.3736605","volume":"15","author":"EA Ostrander","year":"2005","unstructured":"Ostrander EA, Wayne RK: The canine genome. Genome Res. 2005, 15: 1706-1716. 10.1101\/gr.3736605.","journal-title":"Genome Res"},{"key":"109_CR10","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/nrg1492","volume":"5","author":"NB Sutter","year":"2004","unstructured":"Sutter NB, Ostrander EA: Dog star rising: the canine genetic system. Nat Rev Genet. 2004, 5: 900-910. 10.1038\/nrg1492.","journal-title":"Nat Rev Genet"},{"key":"109_CR11","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1111\/j.1478-3231.2006.01277.x","volume":"26","author":"B Spee","year":"2006","unstructured":"Spee B, Arends B, van den Ingh TSGAM, Brinkhof B, Nederbragt H, Ijzer J, Roskams T, Penning LC, Rothuizen J: Transforming growth factor beta-1 signalling in canine hepatic diseases: new models for human fibrotic liver pathologies. Liver Int. 2006, 26: 716-725. 10.1111\/j.1478-3231.2006.01277.x.","journal-title":"Liver Int"},{"key":"109_CR12","volume-title":"Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Disease","author":"DC Twedt","year":"2006","unstructured":"Twedt DC, van den Ingh TSGAM, Charles JA: Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Disease. 2006, Saunders Elsevier"},{"key":"109_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cell.2006.01.008","volume":"124","author":"MW Neff","year":"2006","unstructured":"Neff MW, Rine J: A fetching model organism. Cell. 2006, 124: 229-231. 10.1016\/j.cell.2006.01.008.","journal-title":"Cell"},{"key":"109_CR14","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/S1072-7515(03)00374-0","volume":"197","author":"LG Koniaris","year":"2003","unstructured":"Koniaris LG, McKillop IH, Schwartz SI, Zimmers TA: Liver regeneration. J Am Coll Surg. 2003, 197: 634-659. 10.1016\/S1072-7515(03)00374-0.","journal-title":"J Am Coll Surg"},{"key":"109_CR15","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/nrm1261","volume":"4","author":"C Birchmeier","year":"2003","unstructured":"Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF: Met, metastasis, motility and more. Nat Rev Mol Cell Biol. 2003, 4: 915-925. 10.1038\/nrm1261.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"109_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bbapap.2003.11.009","volume":"1697","author":"M Hanada","year":"2004","unstructured":"Hanada M, Feng J, Hemmings BA: Structure, regulation and function of PKB\/AKT--a major therapeutic target. Biochim Biophys Acta. 2004, 1697: 3-16.","journal-title":"Biochim Biophys Acta"},{"key":"109_CR17","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.bbrc.2003.04.002","volume":"309","author":"J Okano","year":"2003","unstructured":"Okano J, Shiota G, Matsumoto K, Yasui S, Kurimasa A, Hisatome I, Steinberg P, Murawaki Y: Hepatocyte growth factor exerts a proliferative effect on oval cells through the PI3K\/AKT signaling pathway. Biochem Biophys Res Commun. 2003, 309: 298-304. 10.1016\/j.bbrc.2003.04.002.","journal-title":"Biochem Biophys Res Commun"},{"key":"109_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/030098588302000205","volume":"20","author":"AM Bennett","year":"1983","unstructured":"Bennett AM, Davies JD, Gaskell CJ, Lucke VM: Lobular dissecting hepatitis in the dog. Vet Pathol. 1983, 20: 179-188.","journal-title":"Vet Pathol"},{"key":"109_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1939-1676.1994.tb03219.x","volume":"8","author":"TSGAM van den Ingh","year":"1994","unstructured":"van den Ingh TSGAM, Rothuizen J: Lobular dissecting hepatitis in juvenile and young adult dogs. J Vet Intern Med. 1994, 8: 217-220.","journal-title":"J Vet Intern Med"},{"key":"109_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1478-3231.2004.0926.x","volume":"24","author":"T Cramer","year":"2004","unstructured":"Cramer T, Schuppan D, Bauer M, Pfander D, Neuhaus P, Herbst H: Hepatocyte growth factor and c-Met expression in rat and human liver fibrosis. Liver Int. 2004, 24: 335-344. 10.1111\/j.1478-3231.2004.0926.x.","journal-title":"Liver Int"},{"key":"109_CR21","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1091\/mbc.E02-09-0578","volume":"14","author":"DE Hammond","year":"2003","unstructured":"Hammond DE, Carter S, McCullough J, Urbe S, Vande WG, Clague MJ: Endosomal dynamics of Met determine signaling output. Mol Biol Cell. 2003, 14: 1346-1354. 10.1091\/mbc.E02-09-0578.","journal-title":"Mol Biol Cell"},{"key":"109_CR22","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/hep.510230625","volume":"23","author":"F Farinati","year":"1996","unstructured":"Farinati F, Cardin R, D'Errico A, De MN, Naccarato R, Cecchetto A, Grigioni W: Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation. Hepatology. 1996, 23: 1468-1475. 10.1002\/hep.510230625.","journal-title":"Hepatology"},{"key":"109_CR23","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1478-3231.2006.01242.x","volume":"26","author":"A Quaglia","year":"2006","unstructured":"Quaglia A, McStay M, Stoeber K, Loddo M, Caplin M, Fanshawe T, Williams G, Dhillon A: Novel markers of cell kinetics to evaluate progression from cirrhosis to hepatocellular carcinoma. Liver Int. 2006, 26: 424-432. 10.1111\/j.1478-3231.2006.01242.x.","journal-title":"Liver Int"},{"key":"109_CR24","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1128\/JVI.79.3.1569-1580.2005","volume":"79","author":"G Waris","year":"2005","unstructured":"Waris G, Turkson J, Hassanein T, Siddiqui A: Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication. J Virol. 2005, 79: 1569-1580. 10.1128\/JVI.79.3.1569-1580.2005.","journal-title":"J Virol"},{"key":"109_CR25","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1084\/jem.20012127","volume":"196","author":"T Yoshida","year":"2002","unstructured":"Yoshida T, Hanada T, Tokuhisa T, Kosai K, Sata M, Kohara M, Yoshimura A: Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation. J Exp Med. 2002, 196: 641-653. 10.1084\/jem.20012127.","journal-title":"J Exp Med"},{"key":"109_CR26","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.jhep.2005.03.024","volume":"43","author":"P Starkel","year":"2005","unstructured":"Starkel P, de Saeger C, Leclercq I, Strain A, Horsmans Y: Deficient Stat3 DNA-binding is associated with high Pias3 expression and a positive anti-apoptotic balance in human end-stage alcoholic and hepatitis C cirrhosis. J Hepatol. 2005, 43: 687-695. 10.1016\/j.jhep.2005.03.024.","journal-title":"J Hepatol"},{"key":"109_CR27","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1038\/sj.onc.1204372","volume":"20","author":"S Giambartolomei","year":"2001","unstructured":"Giambartolomei S, Covone F, Levrero M, Balsano C: Sustained activation of the Raf\/MEK\/Erk pathway in response to EGF in stable cell lines expressing the Hepatitis C Virus (HCV) core protein. Oncogene. 2001, 20: 2606-2610. 10.1038\/sj.onc.1204372.","journal-title":"Oncogene"},{"key":"109_CR28","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/hep.1840380414","volume":"38","author":"F Furukawa","year":"2003","unstructured":"Furukawa F, Matsuzaki K, Mori S, Tahashi Y, Yoshida K, Sugano Y, Yamagata H, Matsushita M, Seki T, Inagaki Y, Nishizawa M, Fujisawa J, Inoue K: p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts. Hepatology. 2003, 38: 879-889.","journal-title":"Hepatology"},{"key":"109_CR29","first-page":"G629","volume":"276","author":"S Gupta","year":"1999","unstructured":"Gupta S, Rajvanshi P, Aragona E, Lee CD, Yerneni PR, Burk RD: Transplanted hepatocytes proliferate differently after CCl4 treatment and hepatocyte growth factor infusion. Am J Physiol. 1999, 276: G629-G638.","journal-title":"Am J Physiol"},{"key":"109_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/hep.510300102","volume":"30","author":"K Kosai","year":"1999","unstructured":"Kosai K, Matsumoto K, Funakoshi H, Nakamura T: Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice. Hepatology. 1999, 30: 151-159. 10.1002\/hep.510300102.","journal-title":"Hepatology"},{"key":"109_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/hep.510260111","volume":"26","author":"Y Matsuda","year":"1997","unstructured":"Matsuda Y, Matsumoto K, Yamada A, Ichida T, Asakura H, Komoriya Y, Nishiyama E, Nakamura T: Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis\/cirrhosis. Hepatology. 1997, 26: 81-89. 10.1002\/hep.510260111.","journal-title":"Hepatology"},{"key":"109_CR32","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/S0142-9612(03)00508-8","volume":"25","author":"D Palmes","year":"2004","unstructured":"Palmes D, Spiegel HU: Animal models of liver regeneration. Biomaterials. 2004, 25: 1601-1611. 10.1016\/S0142-9612(03)00508-8.","journal-title":"Biomaterials"},{"key":"109_CR33","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/S0168-8278(98)80284-5","volume":"28","author":"G Corrao","year":"1998","unstructured":"Corrao G, Zambon A, Torchio P, Arico S, La Vecchia C, di Orio F: Attributable risk for symptomatic liver cirrhosis in Italy. Collaborative Groups for the Study of Liver Diseases in Italy. J Hepatol. 1998, 28: 608-614. 10.1016\/S0168-8278(98)80284-5.","journal-title":"J Hepatol"},{"key":"109_CR34","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/00042737-199904000-00006","volume":"11","author":"G Morgan","year":"1999","unstructured":"Morgan G: Beneficial effects of NSAIDs in the gastrointestinal tract. Eur J Gastroenterol Hepatol. 1999, 11: 393-400.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"109_CR35","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/S0140-6736(97)07503-X","volume":"350","author":"R Jalan","year":"1997","unstructured":"Jalan R, Hayes PC: Hepatic encephalopathy and ascites. Lancet. 1997, 350: 1309-1315. 10.1016\/S0140-6736(97)07503-X.","journal-title":"Lancet"},{"key":"109_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/01652176.2004.9695174","volume":"26","author":"SY Boomkens","year":"2004","unstructured":"Boomkens SY, Penning LC, Egberink HF, van den Ingh TSGAM, Rothuizen J: Hepatitis with special reference to dogs. A review on the pathogenesis and infectious etiologies, including unpublished results of recent own studies. Vet Q. 2004, 26: 107-114.","journal-title":"Vet Q"},{"key":"109_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1476-5926-4-3","volume":"4","author":"B Spee","year":"2005","unstructured":"Spee B, Mandigers PJ, Arends B, Bode P, van den Ingh TSGAM, Hoffmann G, Rothuizen J, Penning LC: Differential expression of copper-associated and oxidative stress related proteins in a new variant of copper toxicosis in Doberman pinschers. Comp Hepatol. 2005, 4: 3-10.1186\/1476-5926-4-3.","journal-title":"Comp Hepatol"},{"key":"109_CR38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ab.2006.06.001","volume":"356","author":"B Brinkhof","year":"2006","unstructured":"Brinkhof B, Spee B, Rothuizen J, Penning LC: Development and evaluation of canine reference genes for accurate quantification of gene expression. Anal Biochem. 2006, 356: 36-43. 10.1016\/j.ab.2006.06.001.","journal-title":"Anal Biochem"},{"key":"109_CR39","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1476-5926-4-7","volume":"4","author":"B Spee","year":"2005","unstructured":"Spee B, Penning LC, van den Ingh TSGAM, Arends B, Ijzer J, van Sluijs FJ, Rothuizen J: Regenerative and fibrotic pathways in canine hepatic portosystemic shunt and portal vein hypoplasia, new models for clinical hepatocyte growth factor treatment. Comp Hepatol. 2005, 4: 7-10.1186\/1476-5926-4-7.","journal-title":"Comp Hepatol"}],"container-title":["Comparative Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-5926-6-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T22:49:46Z","timestamp":1630450186000},"score":1,"resource":{"primary":{"URL":"https:\/\/comparative-hepatology.biomedcentral.com\/articles\/10.1186\/1476-5926-6-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,31]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["109"],"URL":"https:\/\/doi.org\/10.1186\/1476-5926-6-8","relation":{},"ISSN":["1476-5926"],"issn-type":[{"value":"1476-5926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,31]]},"assertion":[{"value":"19 December 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"8"}}